05/03/2026
Optimizing NAFL Treatments with the Novel MOSAIC 3D CCT – New Publication!
Our early clinical experience with MOSAIC 3D CCT demonstrates promising improvements in facial skin quality, supported by patient-reported outcomes, blinded expert evaluation, and objective imaging analysis.
Treatments were well tolerated, with only transient erythema and edema observed and no cases of post-inflammatory hyperpigmentation (PIH).